Search results
Found 597 matches for
NIHR Health Technology Aassessment is funding a new study looking at the risks and benefits of first line osteoporosis medications (oral bisphosphonates) amongst patients suffering from chronic kidney disease, led by Associate Professor Daniel Prieto-Alhambra of NDORMS.
Ensuring an inclusive and healthy working environment, empowering individuals and building collegiality
Tuesday, 26 November 2024, 12pm to 1pm
How research is managed and undertaken, How research ensures value
Tuesday, 04 March 2025, 12pm to 1pm